Hologic accepts 92.1% of Third Wave shares, begins subsequent offering period

By Lisa Kerner

Charlotte, N.C., July 17 - Hologic, Inc. said it accepted approximately 45,225,950 shares, or about 92.1%, of Third Wave Technologies, Inc. common stock in the tender offer ended July 16. The offer began on June 18.

Thunder Tech Corp., Hologic's wholly owned subsidiary, began a subsequent offering period for all the remaining Third Wave shares at the same $11.25-per-share price paid in the original offer.

The subsequent offering period ends at midnight ET on July 23, according to a Hologic news release.

As previously reported, Hologic agreed to acquire Third Wave for $580 million in a bid to accelerate the growth of Hologic's diagnostics division.

The Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period in June in connection with the pending merger.

Hologic is a Bedford, Mass.-based medical technologies company.

Based in Madison, Wis., Third Wave develops molecular diagnostic reagents.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.